HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo
暂无分享,去创建一个
S. Grant | M. Muschen | Yun Dai | Lora B. Kramer | Elisa Attkisson | N. Kolluri | Nguyen Nguyen | Tri Nguyen | Nicholas Jordan | N. Nguyen